Elite members get real-time data, technical charting, alerts, and no ads - starting at $24.96/mo.

Try Elite for Free

E

ENGN

enGene Therapeutics Inc

1.77

Nov 09 • 3:59 PM ET +0.02 (1.14%)

1.80

Aftermarket • 7:37 PM ET +0.03 (1.69%)

Healthcare Biotechnology Canada Micro NASD

Peers: CGON TARA IBRX URGN AURA GNLX INO REPL JNJ CTMX

Scroll to Statements

Index	-
Market Cap	118.62M
Enterprise Value	-114.51M
Income	-130.36M
Sales	0.00M
Book/sh	3.44
Cash/sh	3.98
Dividend Est.	-
Dividend TTM	-
Dividend Ex-Date	-
Dividend Gr. 3/5Y	- -
Payout	-
Employees	82
IPO	Feb 01, 2022

P/E	-
Forward P/E	-
PEG	-
P/S	-
P/B	0.52
P/C	0.45
P/FCF	-
EV/EBITDA	-
EV/Sales	-
Quick Ratio	10.21
Current Ratio	10.21
Debt/Eq	0.14
LT Debt/Eq	0.13
Option/Short	Yes / Yes

EPS (ttm)	-2.08
EPS next Y	-1.50
EPS next Q	-0.46
EPS this Y	20.83%
EPS next Y	17.38%
EPS next 5Y	23.88%
EPS past 3/5Y	- -255.92%
Sales past 3/5Y	- -
EPS Y/Y TTM	-9.75%
Sales Y/Y TTM	-
EPS Q/Q	17.85%
Sales Q/Q	-
Earnings	Sep 08 BMO
EPS/Sales Surpr.	-10.17% -

Insider Own	57.56%
Insider Trans	0.01%
Inst Own	42.49%
Inst Trans	-21.74%
ROA	-48.84%
ROE	-60.50%
ROIC	-49.92%
Gross Margin	-
Oper. Margin	-
Profit Margin	-
SMA20	9.43%
SMA50	-0.30%
SMA200	-57.03%
Trades

Shs Outstand	67.01M
Shs Float	28.44M
Short Float	5.28%
Short Ratio	1.86
Short Interest	1.50M
52W High	12.25 -85.55%
52W Low	1.40 26.43%
Volatility	8.36% 6.26%
ATR (14)	0.10
RSI (14)	56.05
Beta	-0.26
Rel Volume	1.06
Avg Volume	806.45K
Volume	848,998

Perf Week	22.07%
Perf Month	2.31%
Perf Quarter	-2.75%
Perf Half Y	18.79%
Perf YTD	-80.40%
Perf Year	-70.79%
Perf 3Y	-79.89%
Perf 5Y	-
Perf 10Y	-
Recom	2.30
Target Price	3.50
Prev Close	1.75
Price	1.77
Change %	1.14%

Affiliate • Advertise • APIs • Careers • Contact • Blog • Help • Privacy • Follow us on X • Do Not Sell My Personal Information

Stock quotes delayed by 1 minute. Futures and options delayed by 15 minutes.
Copyright © 2007-2026 Finviz.com. All Rights Reserved. Export All Screener Data (CSV)